Clinical Trial Update: Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma

View source ↗

Summary

An ongoing clinical trial is evaluating a combination of chemotherapy, immunotherapy, and targeted therapy for cholangiocarcinoma, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Cholangiocarcinoma | Status: RECRUITING